Zscaler Other Income (Expense) increased by 126.4% to $803.00K in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 116.3%, from -$4.94M to $803.00K. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a 47.9% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $71.00K | $329.00K | -$589.00K | -$844.00K | -$2.00M | -$774.00K | -$863.00K | $141.00K | -$809.00K | -$331.00K | -$1.21M | $172.00K | -$927.00K | -$1.78M | -$652.00K | -$4.94M | $677.00K | -$762.00K | -$3.04M | $803.00K |
| QoQ Change | — | +363.4% | -279.0% | -43.3% | -137.1% | +61.3% | -11.5% | +116.3% | -673.8% | +59.1% | -266.2% | +114.2% | -639.0% | -92.3% | +63.4% | -657.1% | +113.7% | -212.6% | -298.8% | +126.4% |
| YoY Change | — | — | — | — | <-999% | -335.3% | -46.5% | +116.7% | +59.6% | +57.2% | -40.4% | +22.0% | -14.6% | -438.7% | +46.2% | <-999% | +173.0% | +57.3% | -366.1% | +116.3% |